Tag: #hydroxychroquine

Vaayath > #hydroxychroquine

admin
April 25, 2020
Pharma News,Uncategorized

Share Now

EMA reminds of risk of serious side effects with Chloroquine and Hydroxychloroquine

April 25, 2020 European Medicines Agency (EMA) has reminded again regarding serious side effects associated with the use of Chloroquine and Hydroxychloroquine in patients suffering from COVID-19. EMA in their bulletin has stated that “Chloroquine and hydroxychloroquine are known to…

Recent Post

Loan Licensing in Pharmaceutical Manufacturing: Key Principles, Guidelines, and Regulatory Framework
Safe Handling of Narcotic and Psychotropic Drugs in a Wholesale Warehouse: A Complete Guide
Understanding the Requirements for a Validation Master Plan (VMP) as per Regulatory Agencies: USFDA, EU GMP, MHRA, and PIC/S
Complete Procedure to Meet CDSCO License Mandate of Class C & D Non-Notified Medical Devices
Complete list of approved FDC

Vaayath is a leading provider of comprehensive pharma regulatory services, serving as a one-stop destination for all your regulatory needs. With a focus on excellence and a commitment to delivering outstanding results

Quick Links

Home
About us
Why us
Blog
Contact Us

Services

Pharma Regulatory Services
Pharma GMP Services
Pharma Licensing Services

Contacts

SCO 15-16, Second Floor, Shri Balaji Complex, old Ambala Road, Dhakoli, Zirakpur, SAS Nagar , Punjab, 160104

+91 6280051677

vaayath@gmail.com